Overall, the pooled OR of the enrolled 16 studies was 3.38 (95% CI: 2.45–4.66) in a random-effect model, which indicated a strong association between HOXB13 G84E mutation and PCa susceptibility (Figure 3). Here, HOXB13 is linked to posterior cortical atrophy.